<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WASHINGTON, D.C.&nbsp;&nbsp;20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pursuant to Section 13 or 15(d) of the</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):&nbsp;&nbsp;June
13, 2012</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WUHAN GENERAL GROUP (CHINA), INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 34%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Nevada</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or other jurisdiction</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">of incorporation)</P></TD>
    <TD STYLE="width: 33%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>001-34125</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Commission</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">File Number)</P></TD>
    <TD STYLE="width: 33%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>84-1092589</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(IRS Employer</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Identification No.)</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Canglongdao Science Park of Wuhan East
Lake Hi-Tech Development Zone</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Wuhan, Hubei 430200</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>People&rsquo;s Republic of China</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices)
(Zip Code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&rsquo;s telephone number, including
area code:&nbsp;&nbsp;<B>(86) 27-5970-0069</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>N/A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed
since last report.)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<U>see</U> General Instruction
A.2. below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Wingdings; text-autospace: none">&uml;</TD>
    <TD COLSPAN="2" STYLE="text-autospace: none; font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</TD></TR>
<TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; text-autospace: none; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-autospace: none; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Wingdings; text-autospace: none">&uml;</TD>
    <TD COLSPAN="2" STYLE="text-autospace: none; font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</TD></TR>
<TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; text-autospace: none; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-autospace: none; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Wingdings; text-autospace: none">&uml;</TD>
    <TD COLSPAN="2" STYLE="text-autospace: none; font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</TD></TR>
<TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; text-autospace: none; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-autospace: none; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Wingdings; text-autospace: none">&uml;</TD>
    <TD COLSPAN="2" STYLE="text-autospace: none; font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</TD></TR>
<TR>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 92%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD></TR>
</TABLE>
<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 13%; text-autospace: none; font-size: 10pt; font-weight: bold">Item 3.01.</TD>
    <TD STYLE="width: 87%; text-autospace: none; font-size: 10pt; font-weight: bold">Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Withdrawal of request for hearing before
Nasdaq Hearing Panel</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 13, 2012, Wuhan General Group (China),
Inc. (the &ldquo;Company&rdquo;), withdrew its request for a hearing&nbsp;before The NASDAQ Stock Market LLC (&ldquo;Nasdaq&rdquo;)
Hearings Panel. As a result, the Company&rsquo;s common stock (the &ldquo;Common Stock&rdquo;) was suspended from listing on Nasdaq
on June 15, 2012. The Common Stock is currently quoted on the OTCQB Pink Sheets, under the same symbol as it was listed under on
Nasdaq: &ldquo;WUHN&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt; color: black">As
previously disclosed, </FONT>on May 17, 2011, the Company received a letter from the Nasdaq stating that, based on the closing
bid price of the Common Stock for the last 30 consecutive business days, the Company did not meet the minimum bid price requirement
for continued listing set forth in Listing Rule 5550(a)(2) (the &ldquo;Rule&rdquo;).&nbsp; <FONT STYLE="font-size: 10pt">In accordance
with Nasdaq Listing Rule 5810(c)(3)(A), the Company had a grace period of 180 calendar days, until November 14, 2011, to regain
compliance with the minimum bid price requirement.&nbsp;&nbsp;The Company did not regain compliance by November 14, 2011. On November
15, 2011, Nasdaq granted the Company an additional extension of 180 calendar days, until May 11, 2012, to meet the minimum bid
price requirement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 14, 2012, the Company received written
notification (the &ldquo;Notification&rdquo;) from Nasdaq stating that the Company&rsquo;s common stock was subject to&nbsp;delisting
from Nasdaq, pending the Company&rsquo;s opportunity to request a hearing&nbsp;before the Nasdaq Hearings Panel (the &ldquo;Panel&rdquo;).
The Notification stated that the Company had not regained compliance with the Rule and if the Company did not request an appeal
before the Panel on or before May 21, 2012, the Company&rsquo;s common stock would be scheduled for delisting at the opening of
business on May 23, 2012.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As previously reported, the Company determined
that it would appeal Nasdaq&rsquo;s determination, and it submitted a request for a hearing before the Panel on May 18, 2012, which
stayed the delisting of the Common Stock pending the Panel&rsquo;s decision. However, the Company withdrew its request for a hearing
before the Panel on June 13, 2012, and as a result, the Common Stock was suspended from listing on Nasdaq at the open of business
on June 15, 2012. In a letter from Nasdaq dated June 13, 2012, Nasdaq stated that it will file a Form 25 Notification of Delisting
with the Securities Exchange Commission when all internal appeal periods have run, which will delist the Common Stock from Nasdaq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Non-compliance with Nasdaq Listing Rule
5605</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to not complying with the Rule,
the Company remained non-compliant with Nasdaq Listing Rule 5605. On December 12, 2011, David K. Karnes, an independent director
and a member of the Company&rsquo;s Audit Committee and Compensation Committee, decided not to stand for re-election as a member
of the Company&rsquo;s board of directors (the &ldquo;Board&rdquo;) at the Company&rsquo;s annual meeting on December 28, 2011.
As a result of Mr. Karnes&rsquo;s departure, the Company was not in compliance with Nasdaq Listing Rule 5605, as the Board was
no longer comprised of a majority of independent directors and the audit committee of the Board was no longer comprised of at least
three independent directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 29, 2011, the Company received
a letter from Nasdaq indicating that effective as of December 28, 2011 the Company would no longer be in compliance with Nasdaq&rsquo;s
independent director and audit committee requirements as set forth in Nasdaq Listing Rule 5605. Pursuant to Nasdaq Listing Rules
5605(b)(1)(A) and 5605(c)(4)(A), the Company was given a cure period during which it is required to regain compliance with these
listing rules. Under the listing rules, the Company had until the earlier of the Company&rsquo;s next annual stockholders&rsquo;
meeting or December 28, 2012.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 23, 2012, the Board unanimously
appointed Yaojun (Larry) Liu as a member of the Board and as a member of the Audit Committee, to hold office until the next annual
shareholder meeting or until removed from office in accordance with the Company&rsquo;s bylaws. The Board had determined that Mr.
Liu qualifies as independent in accordance with the listing requirements of Nasdaq. As a result of Mr. Liu&rsquo;s appointment
to the Board and the Audit Committee, the Company believed that it has regained compliance with Nasdaq&rsquo;s independent director
and audit committee requirements as set forth in Nasdaq Listing Rule 5605.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 13, 2012, Nasdaq notified the Company
that the appointment of Mr. Liu does not satisfy compliance with Nasdaq Listing Rule 5605. Nasdaq&rsquo;s decision was based on
Mr. Liu&rsquo;s other public company affiliations. Mr. Liu was, and still is, a director and member of the audit committee of a
public company, which had previously been delisted from Nasdaq based on, among other reasons, public interest concerns related
to the alleged misconduct of that company&rsquo;s management.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Other Nasdaq inquiries</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nasdaq has made the following
inquiries of the Company since January 2012:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">1)</TD><TD STYLE="text-align: justify">Nasdaq has inquired about the reasons for the resignation
of Philip Lo from his positions as the Chief Financial Officer and Treasurer of the Company on January 18, 2012.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">2)</TD><TD STYLE="text-align: justify">On May 14, 2012, Nasdaq inquired about the Company&rsquo;s
progress on its internal control deficiencies referenced in the Company&rsquo;s Annual Report on Forms 10-K (the &ldquo;Reports&rdquo;)
for the fiscal years ended December 31, 2011 and December 31, 2010, as the deficiencies listed were identical in both Reports.
Nasdaq was also concerned and inquired about the procedures that were taken by the Company in the guaranteeing of a 2010 loan
that Xu Jie, the Chairman of the Company, had procured from Huaxia Bank, which had been guaranteed by Wuhan Blower Co., Ltd (&ldquo;Wuhan
Blower&rdquo;), a subsidiary of the Company. The said loan was repaid by Wuhan Blower and then Wuhan Blower was paid back by Xu
Jie.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="color: black">3)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: black">Nasdaq </FONT>inquired whether
the Company had properly followed its own procedures in the nominating process when appointing Mr. Liu as a director and member
of the Audit Committee. Specifically, Nasdaq <FONT STYLE="color: black">asked if Mr. Liu&rsquo;s nomination had been presented
to the Nominating Committee for approval and whether Mr. Liu&rsquo;s background had properly been reviewed and vetted.</FONT></TD>
</TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is taking the necessary
steps to rectify all of its internal control deficiencies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-autospace: none">&nbsp;Date:&nbsp;&nbsp;July 2, 2012</TD>
    <TD COLSPAN="3" STYLE="text-autospace: none; font-weight: bold">Wuhan General Group (China), Inc.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-autospace: none">&nbsp;</TD>
    <TD STYLE="text-autospace: none">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-autospace: none">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48%; text-autospace: none">&nbsp;</TD>
    <TD STYLE="width: 5%; text-autospace: none">By:</TD>
    <TD STYLE="width: 32%; border-bottom: black 1pt solid; text-autospace: none; font-style: italic">/s/ Ruilong Qi</TD>
    <TD STYLE="width: 15%; text-autospace: none">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-autospace: none">&nbsp;</TD>
    <TD STYLE="text-autospace: none">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-autospace: none">Name: Ruilong Qi</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-autospace: none">&nbsp;</TD>
    <TD STYLE="text-autospace: none">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-autospace: none">Title:&nbsp;Chief Executive Officer</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="margin: 0"></P>

</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "v316520_8k.htm", "description": "FORM 8-K", "secsgml_size_bytes": 22955}]
{"company-data": {"conformed-name": "WUHAN GENERAL GROUP (CHINA), INC", "cik": "0000842694", "assigned-sic": "3564", "irs-number": "841092589", "state-of-incorporation": "NV", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-34125", "film-number": "12940784"}, "business-address": {"street1": "CANGLONGDAO SCIENCE PARK OF WUHAN", "street2": "EAST LAKE HI-TECH DEVELOPMENT ZONE", "city": "WUHAN, HUBEI", "state": "F4", "zip": "430200", "phone": "011 86 138 7113 6999"}, "mail-address": {"street1": "CANGLONGDAO SCIENCE PARK OF WUHAN", "street2": "EAST LAKE HI-TECH DEVELOPMENT ZONE", "city": "WUHAN, HUBEI", "state": "F4", "zip": "430200"}, "former-company": [{"former-conformed-name": "UNITED NATIONAL FILM CORP", "date-changed": "19920703"}, {"former-conformed-name": "RIVERSIDE CAPITAL INC", "date-changed": "19920511"}]}
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549
________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):  June
13, 2012
WUHAN GENERAL GROUP (CHINA), INC.
(Exact name of registrant as specified in
its charter)
Nevada
(State or other jurisdiction
of incorporation)
001-34125
(Commission
File Number)
84-1092589
(IRS Employer
Identification No.)
Canglongdao Science Park of Wuhan East
Lake Hi-Tech Development Zone
Wuhan, Hubei 430200
People's Republic of China
(Address of principal executive offices)
(Zip Code)
Registrant's telephone number, including
area code:
(86) 27-5970-0069
N/A
(Former name or former address, if changed
since last report.)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (
see
General Instruction
A.2. below):
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 3.01.
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
Withdrawal of request for hearing before
Nasdaq Hearing Panel
On June 13, 2012, Wuhan General Group (China),
Inc. (the "Company"), withdrew its request for a hearing before The NASDAQ Stock Market LLC ("Nasdaq")
Hearings Panel. As a result, the Company's common stock (the "Common Stock") was suspended from listing on Nasdaq
on June 15, 2012. The Common Stock is currently quoted on the OTCQB Pink Sheets, under the same symbol as it was listed under on
Nasdaq: "WUHN".
As
previously disclosed,
on May 17, 2011, the Company received a letter from the Nasdaq stating that, based on the closing
bid price of the Common Stock for the last 30 consecutive business days, the Company did not meet the minimum bid price requirement
for continued listing set forth in Listing Rule 5550(a)(2) (the "Rule").
In accordance
with Nasdaq Listing Rule 5810(c)(3)(A), the Company had a grace period of 180 calendar days, until November 14, 2011, to regain
compliance with the minimum bid price requirement.  The Company did not regain compliance by November 14, 2011. On November
15, 2011, Nasdaq granted the Company an additional extension of 180 calendar days, until May 11, 2012, to meet the minimum bid
price requirement.
On May 14, 2012, the Company received written
notification (the "Notification") from Nasdaq stating that the Company's common stock was subject to delisting
from Nasdaq, pending the Company's opportunity to request a hearing before the Nasdaq Hearings Panel (the "Panel").
The Notification stated that the Company had not regained compliance with the Rule and if the Company did not request an appeal
before the Panel on or before May 21, 2012, the Company's common stock would be scheduled for delisting at the opening of
business on May 23, 2012.
As previously reported, the Company determined
that it would appeal Nasdaq's determination, and it submitted a request for a hearing before the Panel on May 18, 2012, which
stayed the delisting of the Common Stock pending the Panel's decision. However, the Company withdrew its request for a hearing
before the Panel on June 13, 2012, and as a result, the Common Stock was suspended from listing on Nasdaq at the open of business
on June 15, 2012. In a letter from Nasdaq dated June 13, 2012, Nasdaq stated that it will file a Form 25 Notification of Delisting
with the Securities Exchange Commission when all internal appeal periods have run, which will delist the Common Stock from Nasdaq.
Non-compliance with Nasdaq Listing Rule
5605
In addition to not complying with the Rule,
the Company remained non-compliant with Nasdaq Listing Rule 5605. On December 12, 2011, David K. Karnes, an independent director
and a member of the Company's Audit Committee and Compensation Committee, decided not to stand for re-election as a member
of the Company's board of directors (the "Board") at the Company's annual meeting on December 28, 2011.
As a result of Mr. Karnes's departure, the Company was not in compliance with Nasdaq Listing Rule 5605, as the Board was
no longer comprised of a majority of independent directors and the audit committee of the Board was no longer comprised of at least
three independent directors.
On December 29, 2011, the Company received
a letter from Nasdaq indicating that effective as of December 28, 2011 the Company would no longer be in compliance with Nasdaq's
independent director and audit committee requirements as set forth in Nasdaq Listing Rule 5605. Pursuant to Nasdaq Listing Rules
5605(b)(1)(A) and 5605(c)(4)(A), the Company was given a cure period during which it is required to regain compliance with these
listing rules. Under the listing rules, the Company had until the earlier of the Company's next annual stockholders'
meeting or December 28, 2012.
On May 23, 2012, the Board unanimously
appointed Yaojun (Larry) Liu as a member of the Board and as a member of the Audit Committee, to hold office until the next annual
shareholder meeting or until removed from office in accordance with the Company's bylaws. The Board had determined that Mr.
Liu qualifies as independent in accordance with the listing requirements of Nasdaq. As a result of Mr. Liu's appointment
to the Board and the Audit Committee, the Company believed that it has regained compliance with Nasdaq's independent director
and audit committee requirements as set forth in Nasdaq Listing Rule 5605.
On June 13, 2012, Nasdaq notified the Company
that the appointment of Mr. Liu does not satisfy compliance with Nasdaq Listing Rule 5605. Nasdaq's decision was based on
Mr. Liu's other public company affiliations. Mr. Liu was, and still is, a director and member of the audit committee of a
public company, which had previously been delisted from Nasdaq based on, among other reasons, public interest concerns related
to the alleged misconduct of that company's management.
Other Nasdaq inquiries
Nasdaq has made the following
inquiries of the Company since January 2012:
1)
Nasdaq has inquired about the reasons for the resignation
of Philip Lo from his positions as the Chief Financial Officer and Treasurer of the Company on January 18, 2012.
2)
On May 14, 2012, Nasdaq inquired about the Company's
progress on its internal control deficiencies referenced in the Company's Annual Report on Forms 10-K (the "Reports")
for the fiscal years ended December 31, 2011 and December 31, 2010, as the deficiencies listed were identical in both Reports.
Nasdaq was also concerned and inquired about the procedures that were taken by the Company in the guaranteeing of a 2010 loan
that Xu Jie, the Chairman of the Company, had procured from Huaxia Bank, which had been guaranteed by Wuhan Blower Co., Ltd ("Wuhan
Blower"), a subsidiary of the Company. The said loan was repaid by Wuhan Blower and then Wuhan Blower was paid back by Xu
Jie.
3)
Nasdaq
inquired whether
the Company had properly followed its own procedures in the nominating process when appointing Mr. Liu as a director and member
of the Audit Committee. Specifically, Nasdaq
asked if Mr. Liu's nomination had been presented
to the Nominating Committee for approval and whether Mr. Liu's background had properly been reviewed and vetted.
The Company is taking the necessary
steps to rectify all of its internal control deficiencies.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date:  July 2, 2012
Wuhan General Group (China), Inc.
By:
/s/ Ruilong Qi
Name: Ruilong Qi
Title: Chief Executive Officer